1. Home
  2. EXEL vs HMY Comparison

EXEL vs HMY Comparison

Compare EXEL & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • HMY
  • Stock Information
  • Founded
  • EXEL 1994
  • HMY 1950
  • Country
  • EXEL United States
  • HMY South Africa
  • Employees
  • EXEL N/A
  • HMY N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • HMY Precious Metals
  • Sector
  • EXEL Health Care
  • HMY Basic Materials
  • Exchange
  • EXEL Nasdaq
  • HMY Nasdaq
  • Market Cap
  • EXEL 9.4B
  • HMY 7.7B
  • IPO Year
  • EXEL 2000
  • HMY N/A
  • Fundamental
  • Price
  • EXEL $36.85
  • HMY $10.83
  • Analyst Decision
  • EXEL Buy
  • HMY Sell
  • Analyst Count
  • EXEL 18
  • HMY 3
  • Target Price
  • EXEL $37.24
  • HMY $6.60
  • AVG Volume (30 Days)
  • EXEL 2.5M
  • HMY 7.5M
  • Earning Date
  • EXEL 02-11-2025
  • HMY 01-01-0001
  • Dividend Yield
  • EXEL N/A
  • HMY 1.20%
  • EPS Growth
  • EXEL 170.77
  • HMY 75.55
  • EPS
  • EXEL 1.76
  • HMY 0.75
  • Revenue
  • EXEL $2,168,701,000.00
  • HMY $3,362,293,253.00
  • Revenue This Year
  • EXEL $5.36
  • HMY $17.62
  • Revenue Next Year
  • EXEL $10.59
  • HMY $7.93
  • P/E Ratio
  • EXEL $20.87
  • HMY $14.79
  • Revenue Growth
  • EXEL 18.49
  • HMY 24.56
  • 52 Week Low
  • EXEL $20.14
  • HMY $5.41
  • 52 Week High
  • EXEL $37.59
  • HMY $12.49
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 65.59
  • HMY 47.44
  • Support Level
  • EXEL $34.01
  • HMY $11.02
  • Resistance Level
  • EXEL $35.46
  • HMY $12.02
  • Average True Range (ATR)
  • EXEL 1.09
  • HMY 0.36
  • MACD
  • EXEL 0.36
  • HMY -0.18
  • Stochastic Oscillator
  • EXEL 95.70
  • HMY 2.92

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.

Share on Social Networks: